Bio-Connect
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA093393(RETNLB Antibody) at dilution 1/20, on the right is treated with fusion protein. (Original magnification: x200)
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA093393(RETNLB Antibody) at dilution 1/20, on the right is treated with fusion protein. (Original magnification: x200)
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using CSB-PA093393(RETNLB Antibody) at dilution 1/20, on the right is treated with fusion protein. (Original magnification: x200)

RETNLB Antibody

CSB-PA093393
Cusabio
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetRETNLB
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cusabio
  • Product Name
    RETNLB Antibody
  • Delivery Days Customer
    20
  • Applications
    ELISA, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Conjugate
    Unconjugated
  • Gene ID84666
  • Target name
    RETNLB
  • Target description
    resistin like beta
  • Target synonyms
    C/EBP-epsilon regulated myeloid-specific secreted cysteine-rich protein precursor 2; colon and small intestine-specific cysteine-rich protein; colon carcinoma-related gene protein; cysteine-rich secreted A12-alpha-like protein 1; cysteine-rich secreted protein A12-alpha-like 1; cysteine-rich secreted protein FIZZ2; FIZZ1; FIZZ2; found in inflammatory zone 1; HXCP2; RELMb; RELMbeta; RELM-beta; resistin-like beta; XCP2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ9BQ08
  • Protein Name
    Resistin-like beta
  • Scientific Description
    Resistin-like beta is a protein that in humans is encoded by the RETNLB gene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C
  • UNSPSC
    41116161

Related products

Anti-RETNLB Antibody
Product group Antibodies
Antibodies.com
ApplicationsImmunoHistoChemistry
  • SizePrice
Product group Antibodies
Biomatik
ApplicationsImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
TargetRETNLB
  • SizePrice
Product group Antibodies
Assay Genie
TargetRETNLB
  • SizePrice
Product group Antibodies
LifeSpan BioSciences
ApplicationsWestern Blot, ELISA
TargetRETNLB
  • SizePrice
Product group Antibodies
RayBiotech
ApplicationsWestern Blot
TargetRETNLB
  • SizePrice
Product group Antibodies
Biosynth
  • SizePrice
Immunohistochemical staining of human stomach shows strong cytoplasmic positivity in glandular cells.
Product group Antibodies
Atlas Antibodies
ApplicationsImmunoHistoChemistry
ReactivityHuman
TargetRETNLB
  • SizePrice
Product group Antibodies
Boster Bio
ApplicationsWestern Blot, ELISA
TargetRETNLB
  • SizePrice
Product group Antibodies
Everest Biotech
ApplicationsELISA, ImmunoHistoChemistry
TargetRETNLB
  • SizePrice
Western blot analysis using anti-RELM-beta (human), mAb (HRB 149) (Prod. No. AG-20A-0012) at 1:5000 dilution.1: Human RELM-beta Fc-fusion protein.2: Recombinant human RELM-beta protein.
Product group Antibodies
AdipoGen Life Sciences
ApplicationsWestern Blot, ELISA
TargetRETNLB
  • SizePrice